Divis Laboratories Ltd | DIVI - Operating Expenses

Stock Price
5,968.50
Daily Change
-33.50 -0.56%
Monthly
-6.21%
Yearly
1.43%
Q1 Forecast
5,937.24

Divis Laboratories Ltd reported INR19.4B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Alaunos Therapeutics USD 1.19M 428K Sep/2025
Aurobindo Pharma INR 70.37B 3.66B Sep/2025
Avita Medical AUD 29.57M 1.21M Jun/2025
Dianthus Therapeutics USD 40.68M 5.56M Sep/2025
Divis Laboratories Ltd INR 19.4B 1.47B Sep/2025
Ionis Pharmaceuticals USD 316.9M 4.69M Sep/2025
IQVIA Holdings USD 6.16B 2.7B Sep/2025
Lupin INR 52.27B 3.01B Sep/2025
Moderna USD 1.28B 232M Sep/2025
Organon & Co USD 906M 362M Sep/2025
Revvity USD 600.61M 12.7M Sep/2025
Tectonic Therapeutic USD 21.89M 440K Sep/2025
Tilray USD 237.52M 17.34M Sep/2025
Viatris USD 3.53B 128.7M Sep/2025
Xeris Pharmaceuticals USD 67.65M 590K Sep/2025